Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tangningtongluo in Non-Proliferative Diabetic Retinopathy
NCT05007262Phase 2Unknown
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Start
- Aug 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tangningtongluo, sponsored by Guizhou Bailing Group Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
tangningtongluo
Beyond the preview
Go deeper on NCT05007262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007262.